Shivan J Mehta1,1,1,1, Tanya Khan1,1, Carmen Guerra1,1, Catherine Reitz1,1, Timothy McAuliffe1,1, Kevin G Volpp1,1,1,1, David A Asch1,1,1,1, Chyke A Doubeni1,1. 1. Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Penn Medicine Center for Health Care Innovation, University of Pennsylvania, Philadelphia, PA, USA. Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. Leonard and Madlyn Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Center for Health Equity Research and Promotion, Philadelphia VA Medical Center, Philadelphia, PA, USA.
Abstract
OBJECTIVES: METHODS: : RESULTS: : Patients randomized to opt-in agreed to participate 23.1% of the time, and only 2.5% of those in opt-out chose not to participate. FIT kits were mailed to 22.4% and 93% of patients in opt-in and opt-out arms, respectively. In intention-to-screen analysis, patients in the opt-out arm had a higher FIT completion rate (29.1%) than in the opt-in arm (9.6%) (absolute difference 19.5%; 95% confidence interval, 10.9-27.9%; P < .001). Results were similar in subgroup analysis of those sent initial messaging through the EHR portal (9.5% opt-in versus 37.5% in opt-out). CONCLUSIONS: .
RCT Entities:
OBJECTIVES: METHODS: : RESULTS: : Patients randomized to opt-in agreed to participate 23.1% of the time, and only 2.5% of those in opt-out chose not to participate. FIT kits were mailed to 22.4% and 93% of patients in opt-in and opt-out arms, respectively. In intention-to-screen analysis, patients in the opt-out arm had a higher FIT completion rate (29.1%) than in the opt-in arm (9.6%) (absolute difference 19.5%; 95% confidence interval, 10.9-27.9%; P < .001). Results were similar in subgroup analysis of those sent initial messaging through the EHR portal (9.5% opt-in versus 37.5% in opt-out). CONCLUSIONS: .
Authors: Ethan A Halm; Elisabeth F Beaber; Dale McLerran; Jessica Chubak; Douglas A Corley; Carolyn M Rutter; Chyke A Doubeni; Jennifer S Haas; Bijal A Balasubramanian Journal: J Gen Intern Med Date: 2016-06-08 Impact factor: 5.128
Authors: Shivan J Mehta; Jordyn Feingold; Matthew Vandertuyn; Tess Niewood; Catherine Cox; Chyke A Doubeni; Kevin G Volpp; David A Asch Journal: Gastroenterology Date: 2017-07-20 Impact factor: 22.682
Authors: Theodore R Levin; Laura Jamieson; Daniel A Burley; Juan Reyes; Michael Oehrli; Cindy Caldwell Journal: Epidemiol Rev Date: 2011-06-27 Impact factor: 6.222
Authors: John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward Journal: Arch Intern Med Date: 2012-04-09
Authors: Katherine L Milkman; John Beshears; James J Choi; David Laibson; Brigitte C Madrian Journal: Proc Natl Acad Sci U S A Date: 2011-06-13 Impact factor: 12.779
Authors: Ronald E Myers; Randa Sifri; Terry Hyslop; Michael Rosenthal; Sally W Vernon; James Cocroft; Thomas Wolf; Jocelyn Andrel; Richard Wender Journal: Cancer Date: 2007-11-01 Impact factor: 6.860
Authors: Matthew A Goldshore; Shivan J Mehta; Woodrow Fletcher; George Tzanis; Chyke A Doubeni; E Carter Paulson Journal: Am J Prev Med Date: 2020-07 Impact factor: 5.043
Authors: Alicia B W Clifton; Shivan J Mehta; Jocelyn V Wainwright; Shannon N Ogden; Chelsea A Saia; Katharine A Rendle Journal: J Gen Intern Med Date: 2022-01-17 Impact factor: 6.473
Authors: Shivan J Mehta; Vikranth Induru; David Santos; Catherine Reitz; Timothy McAuliffe; Charles Orellana; Kevin G Volpp; David A Asch; Chyke A Doubeni Journal: JAMA Netw Open Date: 2019-08-02